J-Pharma Co., Ltd.

The Japanese government has started a new funding project for pharma bioventures in the country with a new JPY50bn ($420m) budget, aiming to strengthen the domestic ecosystem for drug and vaccine deve

Venture capital investment in biopharmaceutical companies is booming in 2020. And while novel cancer and immuno-oncology programs continue to attract large sums, drug developers working on treatments